Header Logo

Connection

MURALI CHINTAGUMPALA to Neoplasm, Residual

Back to Details
This is a "connection" page, showing publications MURALI CHINTAGUMPALA has written about Neoplasm, Residual.
MURALI CHINTAGUMPALA
Connection Strength
0.233
Neoplasm, Residual
  1. Intensity-modulated radiotherapy (IMRT) in pediatric low-grade glioma. Cancer. 2013 Jul 15; 119(14):2654-9.
    View in: PubMed
    Score: 0.102
  2. A phase II window trial of procarbazine and topotecan in children with high-grade glioma: a report from the children's oncology group. J Neurooncol. 2006 Apr; 77(2):193-8.
    View in: PubMed
    Score: 0.062
  3. Serial assessment of measurable residual disease in medulloblastoma liquid biopsies. Cancer Cell. 2021 11 08; 39(11):1519-1530.e4.
    View in: PubMed
    Score: 0.046
  4. Residual intraretinal retinoblastoma after chemoreduction failure. Arch Ophthalmol. 2012 Feb; 130(2):246-8.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.